Liver transplantation with a twenty-four hour delay and an initial low dose of cyclosporine

Hepato-Gastroenterology

Volumn 43, Issue 8, 1996, Pages 435-439

  Gomez R ^a,c   Moreno, E ^a   Loinaz, C ^a   Gonzalez, I ^a   Michelone, P ^b   Garcia, I ^a   Jimenez, C ^a   Lopez, A ^a   Chamorro, A ^a   Abradelo, M ^a   Castellon C ^a  

^a Medicina General   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c NONE   (Spain)

Author keywords

Cyclosporine A; Liver transplantation

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; DRUG BLOOD LEVEL; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE; TIME;

CREATININE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 9244263002     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Calne RY, White DJ, Thiru S et al. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2:1323-1327.
2. Klompmaker IJ, Haagsma EB, Gouw ASH, Verwer R, Slooff MJH. Azathioprine and prednisolone immunosuppression versus maintenance triple therapy including cyclosporine for orthotopic liver transplantation. Transplantation 1989; 48:814-818.
3. Wilczek H, Ringden O, Tyden G. Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 1985; 39:110.
4. Moreno E, Gomez R, Gonzalez I et al. Neurologic complications in liver transplantation. Acta Neurol Scand 1993; 87:25-31.
5. Eid A, Perkins JD, Rakela J, Krom RAF. Conversion from standart cyclosporine to low-dose cyclosporine in liver transplant recipients:effect on nephrotoxicity and hypertension beyond one year. Transplant Proc 1989; 21:2238-2239.
6. Gonwa TA, Poplawski SC, Husberg BS, Nery JR, Klintmaln. Cyclosporine nephrotoxicity in orthotopic liver transplantation. Transplant Proc 1988; 20:401-404.
7. Morris PJ. Single or multiple drug Therapy. Transplant Proc 1989; 21:820-822.
8. Jarrell BE, Moritz MJ, Radomski J. Cyclosporine. In Maddrey WC. Transplant of the liver. Elsevier Ed., New York, 1988.
9. Faure JL, Causse X, Bergeret A, Meyer F, Paliard P. Cyclosporine induced hemolytic anemia in a liver transplant patient. Transplant Proc 1989; 21:2242-2243.
10. Fung JJ, Thomson AW, Pinna A, Selby RR, Starzl TE. State of immunossuppressive agents in organ transplantation. Transplant Proc 1992; 24:2372-2374.
11. Kohlhaw K, Wonigeit K, Schafer O, Ringe B, Bunzendahl H, Pichlmayr R. Association of very high blood levels of cyclosporin metabolites with clinical complications after liver transplantation. Transplant Proc 1989; 21:2232-2233.
12. Gugenheim J, Samuel D, Saliba F, Castaing D, Bismuth H. Use of cyclosporine A in combination with low-dose corticosteroids and azathioprine in liver transplantation. Transplant Proc 1988; 20:366-368.
13. Lumbreras C, Lizasoain M, Moreno E et al. Major bacterial infections following liver transplantation. A prospective study. Hepato-Gastroenterol 1992; 39:362-365.
14. O'Grady JG, Forbes A, Rolles K, Calne RY, Williams R. An analysis of cyclosporine efficacy and toxicity after liver transplantation. Transplantation 1988; 45:575-579.
15. Kahn D, Mazzaferro V, Cervio G et al. Correlation between dose and level of cyclosporine after orthotopic liver transplantation. Transplant Proc 1989; 21:2240-2241.
16. Klintmalm GBG, Nery JR, Husberg BS, Gonwa TA, Tillery GW. Rejection in liver transplantation. Hepatology 1989; 10:978-985.
17. Schroeder TJ, Weiss MA, Smith RD, Stephens GW, First MR. The efficacy of OKT3 in vascular rejection. Transplantation, 1991; 51:312-315.
18. Dousset B, Hubscher SG, Padbury RT et al. Acute liver allograft rejection- is treatment always necessary?. Transplantation, 1993; 55:529-534.
19. Woodle ES, Thistlethwaite JR, Emond JC, et al. OKT3 therapy for hepatic allograft rejection. Transplantation, 1991; 51:1207-1212.
20. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol, 1987; 11:1-10.
21. Moreno E, Gomez R, Garcia I et al. Liver transplantation in malignant primary hepatic neoplasms. Am J Surg, 1992;163:395-400.
22. Kahan BD. Pharmacokinetics and pharmacodynamics of cyclosporine. Transplant Proc 1989; 21:9-15.
23. Venkataramanan R, Burckhardt GJ, Ptachinski R. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin Liver Dis 1985; 5:357-368.
24. Naoumov NV, Tredger JM, Steward CM et al. Cyclosporine A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction. Gut, 1989; 30:391-396.
25. Sommerauer JF, Grant D, Freeman D, Mineault R, Duff J, Wall W. Effects of cholestasis on cyclosporine metabolism in the pig. Transplant Proc, 1989; 21:835-836.
26. Kahan BD. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985; 40:457-476.
27. Farnsworth A, Hall BM, Ng AB. Renal biopsy morphology in renal transplantation. Am J Surg Pathol 1984; 8: 243-252.
28. Landsberg D, Rae A, Chiu A, Werb R, Taylor P, Chan-Yan C, Manson A. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. Transplant Proc 1989; 21:3323-3324.
29. Van Buren ChT. Cyclosporine: Progress, problems, and perpectives. Surg Clin N Am 1986; 66:435-447.